The History of Hypertension Guidelines in Canada.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
05 2019
Historique:
received: 02 11 2018
revised: 11 01 2019
accepted: 11 01 2019
entrez: 30 4 2019
pubmed: 30 4 2019
medline: 19 2 2020
Statut: ppublish

Résumé

Hypertension guidelines have evolved significantly over the past 40 years and have become a key element in a multipronged strategy to reduce the morbidity and mortality associated with hypertension in Canada. According to many measures, Canada's guidelines have been effective, and have likely been a significant factor in improving population hypertension awareness and control rates and reducing cardiovascular mortality. Canada has created a successful template for guideline creation, implementation, and outcome surveillance that has been adopted by jurisdictions throughout the world. This review provides a history of hypertension guidelines in Canada, along with a reflection on the changing clinical environment in which guidelines are used and how guidelines need to continue to evolve to remain impactful and effective.

Identifiants

pubmed: 31030861
pii: S0828-282X(19)30053-4
doi: 10.1016/j.cjca.2019.01.017
pii:
doi:

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

582-589

Informations de copyright

Copyright © 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Stella S Daskalopoulou (SS)

Division of Internal Medicine, Department of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Ross D Feldman (RD)

St Boniface Hospital Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.

Finlay A McAlister (FA)

Division of General Internal Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Doreen M Rabi (DM)

Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada. Electronic address: doreen.rabi@albertahealthservices.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH